Healthcare Stocks

English health service sets out two-year recovery plan for emergency care

  • January 30, 2023 12:02 AM GMT | Reuters
 English health service sets out two-year recovery plan for emergency care

287 By Alistair Smout LONDON (Reuters) - England's National Health Service (NHS) on Monday announced a two-year recovery plan to help restore emergency care and frontline services, currently struggling

Read More...

U.S. FDA approves Gilead's long-acting HIV drug Sunlenca

U.S. FDA approves Gilead's long-acting HIV drug Sunlenca

  • December 22, 2022 03:44 PM GMT | Reuters

(Adds drug's pricing, details, background) Dec 22 (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences Inc's Sunlenca therapy for HIV infections, paving the way

Read More...
U.S. RESEARCH ROUNDUP-Amgen, Coupa Software, Enphase Energy

U.S. RESEARCH ROUNDUP-Amgen, Coupa Software, Enphase Energy

  • December 22, 2022 03:11 PM GMT | Reuters

Dec 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Coupa Software and Enphase Energy, on Thursday. HIGHLIGHTS

Read More...
England reports 94 deaths due to scarlet fever so far this season

England reports 94 deaths due to scarlet fever so far this season

  • December 22, 2022 02:37 PM GMT | Reuters

(Adds agency comment, background) Dec 22 (Reuters) - England reported 94 deaths, including those of 21 children, from scarlet fever and invasive strep A infections so far this season the UK Health

Read More...
UK Says 94 Deaths Due To Scarlet Fever So Far This Season In England

UK Says 94 Deaths Due To Scarlet Fever So Far This Season In England

  • December 22, 2022 02:02 PM GMT | Reuters

Dec 22 (Reuters) - UK Health Security Agency: * UK SAYS SO FAR THIS SEASON THERE HAVE BEEN 94 DEATHS ACROSS ALL AGE GROUPS IN ENGLAND DUE TO SCARLET FEVER AND INVASIVE GROUP A STREP * UK SAYS SO FAR

Read More...
UK says 94 deaths due to scarlet fever so far this season in England

UK says 94 deaths due to scarlet fever so far this season in England

  • December 22, 2022 01:51 PM GMT | Reuters

(Reuters) - The British government said on Thursday there have been 94 deaths due to scarlet fever and invasive group Strep A infections across all age groups in England so far this season. The UK

Read More...
China COVID deaths probably running above 5,000 per day - UK research firm Airfinity

China COVID deaths probably running above 5,000 per day - UK research firm Airfinity

  • December 22, 2022 11:28 AM GMT | Reuters

BEIJING (Reuters) - More than 5,000 people are probably dying each day from COVID-19 in China, health data firm Airfinity estimated, offering a dramatic contrast to official data from Beijing on the

Read More...
Logistics Development Group Buys 12.8 Mln Ordinary Shares In Alliance Pharma At £0.4611 Per Ordinary Share

Logistics Development Group Buys 12.8 Mln Ordinary Shares In Alliance Pharma At £0.4611 Per Ordinary Share

  • December 22, 2022 10:35 AM GMT | Reuters

Dec 22 (Reuters) - Logistics Development Group PLC : * LOGISTICS DEV GRP - ALLIANCE PHARMA PLC INVESTMENT * LOGISTICS DEVELOPMENT GROUP - BUYS 12.8 MILLION ORDINARY SHARES IN ALLIANCE PHARMA PLC AT AN

Read More...
Immupharma Continues To Work With Partner Avion & External Advisors, On Proposed Updated P140 Clinical Programme For 2023

Immupharma Continues To Work With Partner Avion & External Advisors, On Proposed Updated P140 Clinical Programme For 2023

  • December 22, 2022 07:48 AM GMT | Reuters

Dec 22 (Reuters) - ImmuPharma PLC: * IMMUPHARMA PLC - END OF YEAR UPDATE * IMMUPHARMA PLC - CONTINUES TO WORK WITH PARTNER AVION & EXTERNAL ADVISORS, ON PREPARATIONS AROUND PROPOSED UPDATED P140

Read More...
Okyo Pharma Limited Gets FDA Clearance Of IND Application For OK-101

Okyo Pharma Limited Gets FDA Clearance Of IND Application For OK-101

  • December 22, 2022 07:40 AM GMT | Reuters

Dec 22 (Reuters) - OKYO Pharma Ltd: * U.S. FDA CLEARANCE OF IND APPLICATION FOR OK-101 * OKYO PHARMA ANNOUNCES U.S. FDA CLEARANCE OF IND APPLICATION FOR OK-101 FOR TREATMENT OF DRY EYE DISEASE * PHASE

Read More...
Destiny Pharma To Finalise Phase 3 Plans For Xf-73 Nasal

Destiny Pharma To Finalise Phase 3 Plans For Xf-73 Nasal

  • December 22, 2022 07:26 AM GMT | Reuters

Dec 22 (Reuters) - Destiny Pharma PLC: * DESTINY PHARMA PLC - YEAR END TRADING UPDATE * DESTINY PHARMA PLC - TO FINALISE OUR PHASE 3 PLANS FOR XF-73 NASAL AND INTENSIFY PARTNERING DISCUSSIONS *

Read More...